StegmayrB., KlinkmannH.Dieter Falkenhagen (1942–2015): a multifaceted scientist. Int J Artif Organs.2015; 38(11): 617–623.
3.
CohenJ., VincentJ.L., AdhikariN.K.J.Sepsis: a roadmap for future research. Lancet Infect Dis.2015; 15(5): 581–614.
4.
MarshallJ.C.Why have clinical trials in sepsis failed?Trends Mol Med.201420(4): 195–203.
5.
MarshallJ.C.Sepsis: rethinking the approach to clinical research. J Leukoc Biol.2008; 83(3): 471–82.
6.
RimmeleT., and KellumJ.A.Clinical review: blood purification for sepsis. Crit Care.2011; 15(1): 205.
7.
PengZ., SingbartlK., SimonP.Blood purification in sepsis: a new paradigm. Contrib Nephrol.2010; 165: 322–8.
8.
PanagiotouA., GaiaoS., and CruzD.N.Extracorporeal therapies in sepsis. J Intensive Care Med.2013; 28(5): 281–95.
9.
ShojiH., TaniT., HanasawaK., KodamaM.Extracorporeal endotoxin removal by polymyxin B immobilized fiber cartridge: designing and antiendotoxin efficacy in the clinical application. Ther Apher.1998; 2: 3–12.
10.
KumagaiT., TakeyamaN., YabukiT.Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock. Shock.2010; 34(5): 461–466.
11.
MartinE.L., RanieriV.M.Endotoxin removal by polymyxin B immobilized cartridge inactivates circulating proapoptotic factors. Contrib Nephrol.2010; 167: 65–76.
12.
HarmS., FalkenhagenD., HartmannJ.Endotoxin adsorbents in extracorporeal blood purification: do they fulfill expectations?Int J Artif Organs.2014; 37(3): 222–232.
13.
HartmannJ., HarmS.A New Integrated Technique for the Supportive Treatment of Sepsis. Int J Artif Organs.2017; 40(1): 4–8.
14.
PoberJ.S., SessaW.C.Evolving functions of endothelial cells in inflammation. Nat Rev Immunol.2007; 7(10): 803–815.
15.
SchildbergerA., RossmanithE., EichhornT., StrasslK., WeberV.Monocytes, peripheral blood mononuclear cells, and THP-1 cells exhibit different cytokine expression patterns following stimulation with lipopolysaccharide. Mediators Inflamm.2013; 2013: 697972.
16.
SchildbergerA., BuchacherT., WeberV., and FalkenhagenD.Adsorptive modulation of inflammatory mediators dampens endothelial cell activation. Blood Purif.2011; 32(4): 286–295.
17.
YangS., QiH., KanK.Neutrophil Extracellular Traps Promote Hypercoagulability in Patients with Sepsis. Shock.2017; 47(2): 132–139.
18.
IbaT., MikiT., HashiguchiN., TabeY., NagaokaI.Is the neutrophil a ‘prima donna’ in the procoagulant process during sepsis?Crit Care.2014; 18(4): 230.
19.
PloppaA., KampmannM., JohannesT., HaeberleH.A., NoheB.Effects of different leukocyte subpopulations and flow conditions on leukocyte accumulation during reperfusion. J Vasc Res.2012; 49(2): 169–180.
20.
EichhornT., FischerM.B., WeberV.Mechanisms of Endothelial Activation in Sepsis and Cell Culture Models to Study the Heterogeneous Host Response. Int J Artif Organs.2017; 40(1): 9–14.
21.
StroblK., HarmS., WeberV., HartmannJ.The role of ionized calcium and magnesium in regional citrate anticoagulation and its impact on inflammatory parameters. Int J Artif Organs.2017; 40(1): 15–21.
22.
SemakV., FischerM.B., WeberV.Biomimetic Principles to Develop Blood Compatible Surfaces. Int J Artif Organs.2017; 40(1): 22–30.
YoshizakiT., TabuchiN., van OeverenW., ShibamiyaA., KoyamaT., SunamoriM.PMEA polymer-coated PVC tubing maintains antithrombogenic properties during in vitro whole blood circulation. Int J Artif Organs.2005; 28(8): 834–840.
25.
ZhouG., Al-KhouryH., GrothT.Covalent immobilization of glycosaminoglycans to reduce the inflammatory effects of biomaterials. Int J Artif Organs.2016; 39(1): 37–44.
26.
KöwitschA., ZhouG., GrothT.Medical Application of Glycosaminoglycans - A Review. J Tissue Eng Regener Med.2017. Jan 12. doi: 10.1002/term.2398. [Epub ahead of print].
27.
YangY., KöwitschA., MaN., MäderK., PashkulevaI., ReisR.L., GrothT.Functionality of surface-coupled oxidised glycosaminoglycans towards fibroblast adhesion. J Bioact Compat Polymers.31(2): 191–207.
28.
NiepelM.S., PeschelD., GrothT.Controlling fibroblast adhesion with pH modified polyelectrolyte multilayers. Int J Artif Organs.2011; 34(2): 185–191.
29.
AfratisN., GialeliC., NikitovicD.Glycosaminoglycans: Key players in cancer cell biology and treatment. Febs J.2012; 7(279): 1177–1197.
30.
DickinsonL.E., HoC.C., WangG.M., StebeK.J., GerechtS.Functional surfaces for high-resolution analysis of cancer cell interactions on exogenous hyaluronic acid. Biomaterials.2010: 20(31): 5472–5478.
31.
KöwitschA., ChhalotreA., GrothT.Effect of thiolated glycosaminoglycans on the behavior of breast cancer cells - Towards development of in vitro models of cancer, Int J Artif Organs.2017; 40(1): 31–39.
32.
WalpothB.H., MeyerM., Gaudet-BlavignacC., BaumannP., GilquinP., LovisC.The International Hypothermia Registry (IHR) - Dieter's ESAO Winter Schools & Beat's International Hypothermia Registry. Int J Artif Organs.2017; 40(1): 40–42.